Xtant Medical Holdings logo

Xtant Medical Holdings (XTNT) Q1 2026 Annual Earnings

XTNT·Reported May 13, 2026·Before market open

Xtant Medical Holdings reported Q1 2026 revenue of $20.9M (-36.5% YoY), beat analyst consensus of $20.2M by $719.7K. Diluted EPS came in at $-0.02, missed the $-0.01 consensus by $0.01.

Revenue
$20.9Mbeat by $719.7K
Consensus: $20.2M
Diluted EPS
$-0.02missed by $0.01
Consensus: $-0.01
SEC

SEC Filings

Earnings release8-K · 0001493152-26-022600
Annual report10-K · 0001493152-26-013792

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Xtant Medical Holdings's Q1 2026 earnings report.

Xtant Medical Holdings (XTNT) reported Q1 2026 earnings on May 13, 2026 before market open.

Xtant Medical Holdings reported revenue of $20.9M and diluted EPS of $-0.02 for Q1 2026.

Revenue beat the consensus estimate of $20.2M by $719.7K. EPS missed the consensus estimate of $-0.01 by $0.01.

Compared to the same quarter a year prior, revenue declined 36.5% from $32.9M a year earlier.

You can read the 8-K earnings release (0001493152-26-022600) and the 10-K periodic report (0001493152-26-013792) directly on SEC EDGAR. The filing index links above go to sec.gov.